Cefaly
Cefaly is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer’s quality of life to be markedly improved. It is the solution for most of migraineurs.
Cefaly offers the best safety efficacy ratio compared to current anti-migraine oral medication. It is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer’s quality of life to be markedly improved. It is the solution for most of migraineurs.
Cefaly is an External Trigeminal Nerve Stimulation device (e-TNS) for migraine treatment. A self-adhesive electrode is placed on the forehead and the Cefaly device is magnetically connected to this electrode. Precise micro-impulses are then sent through the electrode to the upper branch of the trigeminal nerve to either relieve the headache pain during a migraine attack (Acute setting) or to prevent future migraine attacks (Prevent setting).
Cefaly is intended for patients who suffer from migraine with or without aura particularly when drug consumption needs to be reduced.
The Acute setting is indicated for the acute treatment of migraine attacks.